TABLE 1.

SURROGATE CONSENT FOR ANCILLARY GENETIC SUBSTUDIES BY PATIENT RACE/ETHNICITY

Patient	Percentage of Surrogate Approval for Genetic Substudies
	Genetic Studies for Parent Study Only (n = 1164)	Future Genetic Studies for Any ARDS-related Research (n = 1164)	Future Genetic Studies for Non–ARDS-related Research (n = 1059)
Race
White	93.8% [92.2–95.4%] (n = 884)	92.3% [90.5–94.1%] (n = 884)	87.6% [85.3–89.9%] (n = 798)
African American	84.8% [79.7–89.9%] (n = 191)	83.8% [75.6–89.0%] (n = 191)	79.1% [73.2–85.0%] (n = 182)
Other	81.0% [69.1–92.3%] (n = 42)	81.0% [69.1–92.3%] (n = 42)	71.4% [56.4–86.4%] (n = 35)
Ethnicity: Hispanic	90.5% [85.6–95.4%] (n = 137)	86.9% [81.3–92.6%] (n = 137)	74.2% [66.6–81.8%] (n = 128)

Data in brackets are 95% confidence intervals.